SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

23 hedge funds and large institutions have $6.84M invested in Salarius Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$273K
2
+$114K
3
+$82.4K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$39.8K
5
VF
Virtu Financial
New York
+$30K

Top Sellers

1
-$1.91M
2
-$621K
3
-$450K
4
SM
Sabby Management
Florida
-$264K
5
Marshall Wace
Marshall Wace
United Kingdom
-$185K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
1
2